Dysregulation of SHP2 signaling (abnormal protein and gene mutation) is involved in Noonan syndrome, Leopard syndrome, metabolic disorder, and several types of cancer, including breast cancer, liver cancer, and leukemia (Zhang et al., 2015; Wang et al., 2021). Here, PTPN11 is linked to liver cancer.